Metraipolis › archive › dc_4904820cf259

Prim-O-glucosylcimifugin ameliorates DSS-induced ulcerative colitis via suppressing NLRP3 inflammasome activation — Europe PMC PMID:41939840

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41939840
DOI
10.3389/fphar.2026.1750305
License (as archived)
solo-consultazione
Archived
2026-11-04T05:23:15.787Z
SHA-256 of the archived text
ec86ba979b5494b22ee412e084d4f7d9514240021b74aa240c4c39f23eead34b
Stable URL of this page
https://metraipolis.com/documento/dc_4904820cf259

How to cite

Prim-O-glucosylcimifugin ameliorates DSS-induced ulcerative colitis via suppressing NLRP3 inflammasome activation — Europe PMC PMID:41939840 — Europe PMC (en), https://europepmc.org/article/MED/41939840 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4904820cf259 (Metraipolis archive dc_4904820cf259, sha256 ec86ba979b5494b22ee412e084d4f7d9514240021b74aa240c4c39f23eead34b)
BibTeX
@misc{dc4904820cf259,
  title = {Prim-O-glucosylcimifugin ameliorates DSS-induced ulcerative colitis via suppressing NLRP3 inflammasome activation — Europe PMC PMID:41939840},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939840},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4904820cf259; sha256 ec86ba979b5494b22ee412e084d4f7d9514240021b74aa240c4c39f23eead34b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939840. Agents can read the archived copy with the MCP tool read_document.